CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Porters five forces analysis
3.4. Market share analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Soaring demand for blood components across the globe
3.5.1.2. Increase in the government initiatives regarding blood donation
3.5.1.3. Newly approved indications for apheresis treatment

3.5.2. Restraints

3.5.2.1. Dearth of skilled professionals
3.5.2.2. Complications associated with the apheresis procedure

3.5.3. Opportunity

3.5.3.1. Rise in the demand for plasma-derived pharmaceuticals

CHAPTER 4: APHERESIS MARKET BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Devices

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Disposables & Reagents

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Software

4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: APHERESIS MARKET BY PROCEDURE

5.1. Overview

5.1.1. Market size and forecast

5.2. Donor/Automated Apheresis

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Therapeutic Apheresis

5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.3. Therapeutic Apheresis Market by Type

5.3.3.1. Market size and forecast
5.3.3.2. Plasma Exchange

5.3.3.2.1. Market size and forecast

5.3.3.3. Stem Cell Harvest

5.3.3.3.1. Market size and forecast

5.3.3.4. Photopheresis

5.3.3.4.1. Market size and forecast

5.3.3.5. Low Density Lipid Removal

5.3.3.5.1. Market size and forecast

5.3.3.6. Other Therapeutic Type

5.3.3.6.1. Market size and forecast

5.3.4. Therapeutic Apheresis Market by Specialty

5.3.4.1. Market size and forecast
5.3.4.2. Hematology

5.3.4.2.1. Market size and forecast

5.3.4.3. Neurology

5.3.4.3.1. Market size and forecast

5.3.4.4. Oncology

5.3.4.4.1. Market size and forecast

5.3.4.5. Other Therapeutic Application

5.3.4.5.1. Market size and forecast

CHAPTER 6: APHERESIS MARKET BY METHOD

6.1. Overview

6.1.1. Market size and forecast

6.2. Centrifugation

6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.2.3. Intermittent Flow Centrifugation

6.2.3.1. Market size and forecast

6.2.4. Continuous Flow Centrifugation

6.2.4.1. Market size and forecast

6.3. Membrane Separation

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Selective Adsorption

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: APHERESIS MARKET BY COMPONENT

7.1. Overview

7.1.1. Market size and forecast

7.2. Plasma (Plasmapheresis)

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Platelets (Plateletpheresis)

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Leukocytes (Leukapheresis)

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

7.5. Lymphocytes (Lymph apheresis)

7.5.1. Market size and forecast
7.5.2. Market analysis, by country

7.6. RBC's (Erythropheresis)

7.6.1. Market size and forecast
7.6.2. Market analysis, by country

CHAPTER 8: APHERESIS MARKET BY END USER

8.1. Overview

8.1.1. Market size and forecast

8.2. Blood Centers

8.2.1. Market size and forecast
8.2.2. Market analysis, by country

8.3. Hospitals

8.3.1. Market size and forecast
8.3.2. Market analysis, by country

8.4. Other end users

8.4.1. Market size and forecast
8.4.2. Market analysis, by country

CHAPTER 9: APHERESIS MARKET BY REGION

9.1. Overview

9.1.1. Market size and forecast

9.2. North America

9.2.1. Key trends and opportunities
9.2.2. North America market size & forecast by country
9.2.3. North America market size & forecast by product
9.2.4. North America market size & forecast by method
9.2.5. North America market size & forecast by procedure
9.2.6. North America market size & forecast by component
9.2.7. North America market size & forecast by end user

9.2.7.1. U.S. market size & forecast by product
9.2.7.2. U.S. market size & forecast by method
9.2.7.3. U.S. market size & forecast by procedure
9.2.7.4. U.S. market size & forecast by component
9.2.7.5. U.S. market size & forecast by end user
9.2.7.6. Canada market size & forecast by product
9.2.7.7. Canada market size & forecast by method
9.2.7.8. Canada market size & forecast by procedure
9.2.7.9. Canada market size & forecast by component
9.2.7.10. Canada market size & forecast by end user
9.2.7.11. Mexico market size & forecast by product
9.2.7.12. Mexico market size & forecast by method
9.2.7.13. Mexico market size & forecast by procedure
9.2.7.14. Mexico market size & forecast by component
9.2.7.15. Mexico market size & forecast by end user

9.3. Europe

9.3.1. Key trends and opportunities
9.3.2. Europe market size & forecast for apheresis market by country
9.3.3. Europe market size & forecast by product
9.3.4. Europe market size & forecast by method
9.3.5. Europe market size & forecast by procedure
9.3.6. Europe market size & forecast by component
9.3.7. Europe market size & forecast by end user

9.3.7.1. Germany market size & forecast by product
9.3.7.2. Germany market size & forecast by method
9.3.7.3. Germany market size & forecast by procedure
9.3.7.4. Germany market size & forecast by component
9.3.7.5. Germany market size & forecast by end user
9.3.7.6. France market size & forecast by product
9.3.7.7. France market size & forecast by method
9.3.7.8. France market size & forecast by procedure
9.3.7.9. France market size & forecast by component
9.3.7.10. France market size & forecast by end user
9.3.7.11. UK market size & forecast by product
9.3.7.12. UK market size & forecast by method
9.3.7.13. UK market size & forecast by procedure
9.3.7.14. UK market size & forecast by component
9.3.7.15. UK market size & forecast by end user
9.3.7.16. Italy market size & forecast by product
9.3.7.17. Italy market size & forecast by method
9.3.7.18. Italy market size & forecast by procedure
9.3.7.19. Italy market size & forecast by component
9.3.7.20. Italy market size & forecast by end user
9.3.7.21. Spain market size & forecast by product
9.3.7.22. Spain market size & forecast by method
9.3.7.23. Spain market size & forecast by procedure
9.3.7.24. Spain market size & forecast by component
9.3.7.25. Spain market size & forecast by end user
9.3.7.26. Rest of Europe market size & forecast by product
9.3.7.27. Rest of Europe market size & forecast by method
9.3.7.28. Rest of Europe market size & forecast by procedure
9.3.7.29. Rest of Europe market size & forecast by component
9.3.7.30. Rest of Europe market size & forecast by end user

9.4. Asia-Pacific

9.4.1. Key trends and opportunities
9.4.2. Asia-Pacific market size & forecast by country
9.4.3. Asia-Pacific market size & forecast by product
9.4.4. Asia-Pacific market size & forecast by method
9.4.5. Asia-Pacific market size & forecast by procedure
9.4.6. Asia-Pacific market size & forecast by component
9.4.7. Asia-Pacific market size & forecast by end user

9.4.7.1. Japan market size & forecast by product
9.4.7.2. Japan market size & forecast by method
9.4.7.3. Japan market size & forecast by procedure
9.4.7.4. Japan market size & forecast by component
9.4.7.5. Japan market size & forecast by end user
9.4.7.6. China market size & forecast by product
9.4.7.7. China market size & forecast by method
9.4.7.8. China market size & forecast by procedure
9.4.7.9. China market size & forecast by component
9.4.7.10. China market size & forecast by end user
9.4.7.11. India market size & forecast by product
9.4.7.12. India market size & forecast by method
9.4.7.13. India market size & forecast by procedure
9.4.7.14. India market size & forecast by component
9.4.7.15. India market size & forecast by end user
9.4.7.16. Australia market size & forecast by product
9.4.7.17. Australia market size & forecast by method
9.4.7.18. Australia market size & forecast by procedure
9.4.7.19. Australia market size & forecast by component
9.4.7.20. Australia market size & forecast by end user
9.4.7.21. Rest of Asia-Pacific market size & forecast by product
9.4.7.22. Rest of Asia-Pacific market size & forecast by method
9.4.7.23. Rest of Asia-Pacific market size & forecast by procedure
9.4.7.24. Rest of Asia-Pacific market size & forecast by component
9.4.7.25. Rest of Asia-Pacific market size & forecast by end user

9.5. LAMEA

9.5.1. Key trends and opportunities
9.5.2. LAMEA market size & forecast by country
9.5.3. LAMEA market size & forecast by product
9.5.4. LAMEA market size & forecast by method
9.5.5. LAMEA market size & forecast by procedure
9.5.6. LAMEA market size & forecast by component
9.5.7. LAMEA market size & forecast by end user

9.5.7.1. Brazil market size & forecast by product
9.5.7.2. Brazil market size & forecast by method
9.5.7.3. Brazil market size & forecast by procedure
9.5.7.4. Brazil market size & forecast by component
9.5.7.5. Brazil market size & forecast by end user
9.5.7.6. South Africa market size & forecast by product
9.5.7.7. South Africa market size & forecast by method
9.5.7.8. South Africa market size & forecast by procedure
9.5.7.9. South Africa market size & forecast by component
9.5.7.10. South Africa market size & forecast by end user
9.5.7.11. Turkey market size & forecast by product
9.5.7.12. Turkey market size & forecast by method
9.5.7.13. Turkey market size & forecast by procedure
9.5.7.14. Turkey market size & forecast by component
9.5.7.15. Turkey market size & forecast by end user
9.5.7.16. Saudi Arabia market size & forecast by product
9.5.7.17. Saudi Arabia market size & forecast by method
9.5.7.18. Saudi Arabia market size & forecast by procedure
9.5.7.19. Saudi Arabia market size & forecast by component
9.5.7.20. Saudi Arabia market size & forecast by end user
9.5.7.21. Rest of LAMEA market size & forecast by product
9.5.7.22. Rest of LAMEA market size & forecast by method
9.5.7.23. Rest of LAMEA market size & forecast by procedure
9.5.7.24. Rest of LAMEA market size & forecast by component
9.5.7.25. Rest of LAMEA market size & forecast by end user

CHAPTER 10: COMPANY PROFILE

10.1. Haemonetics Corporation

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Business performance
10.1.5. Key strategic moves and developments

10.2. Fresenius Kabi

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Business performance
10.2.5. Key strategic moves and developments

10.3. Terumo BCT, Inc.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Business performance
10.3.5. Key strategic moves and developments

10.4. Asahi Kasei Medical Co., Ltd.

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Business performance
10.4.5. Key strategic moves and developments

10.5. HemaCare Corporation

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Business performance
10.5.5. Key strategic moves and developments

10.6. Kaneka Corporation

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Business performance
10.6.5. Key strategic moves and developments

10.7. Kawasumi Laboratories Inc.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Business performance
10.7.5. Key strategic moves and developments

10.8. Cerus Corporation

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves and developments

10.9. B. Braun Melsungen AG

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves and developments

10.10. Nikkiso Co., Ltd.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Business performance
10.10.5. Key strategic moves and developments